LMR Partners’s Nurix Therapeutics NRIX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q3
$3.11M Buy
+131,011
New +$3.27M 0.01% 828

Other funds holding NRIX

LMR Partners's NRIX Position: Q3 2026 in Review

LMR Partners opened a new position in Nurix Therapeutics (NRIX) in Q3 2026: 131,011 shares worth $3.11M. The stake represents 0.01% of the portfolio and ranks #828 among its holdings.

234 funds tracked by Wall St. Rank hold NRIX as of Q3 2026.

  • LMR Partners held 131,011 shares of Nurix Therapeutics worth $3.11M as of Q3 2026.
  • Nurix Therapeutics was a new LMR Partners position in Q3 2026.
  • Nurix Therapeutics made up 0.01% of LMR Partners's portfolio in Q3 2026, its #828 holding.
  • 234 funds tracked by Wall St. Rank held Nurix Therapeutics as of Q3 2026.

Based on LMR Partners's 13F filing for Q3 2026, filed 16 Nov 2026.